Acutus Medical Inc. (AFIB): Price and Financial Metrics

Acutus Medical Inc. (AFIB): $0.26

0.07 (+34.43%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

F

AFIB Price/Volume Stats

Current price $0.26 52-week high $1.09
Prev. close $0.19 52-week low $0.16
Day low $0.18 Volume 6,917,900
Day high $0.27 Avg. volume 2,600,306
50-day MA $0.20 Dividend yield N/A
200-day MA $0.47 Market Cap 7.68M

AFIB Stock Price Chart Interactive Chart >

AFIB Stock Summary

  • AFIB has a higher market value than just 3.1% of US stocks; more precisely, its current market capitalization is $5,831,452.
  • AFIB's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.27 -- higher than only 3.35% of US-listed equities with positive expected earnings growth.
  • Of note is the ratio of ACUTUS MEDICAL INC's sales and general administrative expense to its total operating expenses; 99.8% of US stocks have a lower such ratio.
  • If you're looking for stocks that are quantitatively similar to ACUTUS MEDICAL INC, a group of peers worth examining would be BLUE, AGIO, IMRN, VJET, and ASTR.
  • Visit AFIB's SEC page to see the company's official filings. To visit the company's web site, go to www.acutusmedical.com.

AFIB Valuation Summary

  • AFIB's price/sales ratio is 0.3; this is 86.36% lower than that of the median Healthcare stock.
  • AFIB's EV/EBIT ratio has moved up 7.2 over the prior 41 months.

Below are key valuation metrics over time for AFIB.

Stock Date P/S P/B P/E EV/EBIT
AFIB 2023-12-29 0.3 0.2 -0.2 -0.5
AFIB 2023-12-28 0.3 0.2 -0.2 -0.5
AFIB 2023-12-27 0.3 0.2 -0.2 -0.5
AFIB 2023-12-26 0.3 0.2 -0.2 -0.5
AFIB 2023-12-22 0.3 0.2 -0.2 -0.5
AFIB 2023-12-21 0.3 0.2 -0.2 -0.5

AFIB's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AFIB has a Quality Grade of F, ranking ahead of 1.4% of graded US stocks.
  • AFIB's asset turnover comes in at 0.079 -- ranking 159th of 186 Medical Equipment stocks.
  • 500 - Internal server error

The table below shows AFIB's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.079 -0.743 -0.714
2021-03-31 0.066 -0.876 -0.809
2020-12-31 0.060 -0.877 -0.878

AFIB Price Target

For more insight on analysts targets of AFIB, see our AFIB price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $20.67 Average Broker Recommendation 1.6 (Moderate Buy)

Acutus Medical Inc. (AFIB) Company Bio


Acutus Medical develops medical technologies to treat complex cardiac arrhythmia. The company's platform displays the heart’s true activation pattern, turning the chaos of a complex arrhythmia into a clear vision for electrophysiologists. Acutus Medical is a privately funded company founded in 2011 and based in Carlsbad, California. Its products are co-developed in the U.S. and Europe with an exceptional team of medical scientists, biomedical engineers, and other professionals.


AFIB Latest News Stream


Event/Time News Detail
Loading, please wait...

AFIB Latest Social Stream


Loading social stream, please wait...

View Full AFIB Social Stream

Latest AFIB News From Around the Web

Below are the latest news stories about ACUTUS MEDICAL INC that investors may wish to consider to help them evaluate AFIB as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time to start Tuesday trading with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning!

William White on InvestorPlace | November 21, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Thursday!

William White on InvestorPlace | November 16, 2023

Acutus laying off 65% of employees to focus solely on Medtronic heart device deal

The company has decided to exit the mapping and ablation business and focus its remaining cash on the Medtronic partnership.

Yahoo | November 10, 2023

Acutus Medical Inc (AFIB) Reports Substantial Revenue Growth in Q3 2023 Despite Negative Gross ...

Improvements in Operating Efficiency and Strategic Partnerships Drive Performance

Yahoo | November 8, 2023

Acutus Medical Reports Third Quarter 2023 Financial Results

CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the third quarter of 2023. Recent Highlights: Third quarter revenue of $5.2 million grew 44% year-over-year, led by strong growth in distribution revenue from sales of left-heart access products to MedtronicRegistered significant year-over-year reductions in both GAAP and non-GAAP operating expenses and cash burn, resulting from disciplined focus on expen

Yahoo | November 8, 2023

Read More 'AFIB' Stories Here

AFIB Price Returns

1-mo 31.31%
3-mo 33.20%
6-mo -62.61%
1-year -67.90%
3-year -98.32%
5-year N/A
YTD 28.78%
2023 -82.44%
2022 -66.28%
2021 -88.16%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!